Home › Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray
 

Keywords :   


Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray

2016-01-03 18:15:54| Biotech - Topix.net

In related news, CMO Alfred Sandrock sold 441 shares of the business's stock in a transaction that occurred on Friday, December 4th. The stock was sold at an average price of $277.00, for a total transaction of $122,157.00.

Tags: rating increased piper overweight

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »